Answers are grounded in this paper and cite their sources.
Case study explores using NLP and open data to identify drugs for glioblastoma therapy, indicating new repurposing possibilities.
The development and discovery of new drugs is a long, costly and risky endeavour with low rate of success. It is a well-known practice to identify new uses for already existing drugs or known active compounds, referred to as “drug repositioning’’ or “drug repurposing This case study uses NLP techniques and open data sources to explore their potential in identifying drugs for glioblastoma therapy beyond the obvious choices documented in established databases like DrugBank.
No takes yet. Share an insight, caveat, or question.
Marxer et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: